Premier Biomedical, Inc. (BIEI)
| Previous close | 0.0014 |
| Open | 0.0014 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.0013 - 0.0014 |
| 52-week range | 0.0005 - 0.0017 |
| Volume | |
| Avg. volume | 1,752,435 |
| Market cap | 1.6M |
| Beta (5Y monthly) | -4.16 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswirePremier Graphene, Inc. (BIEI) Demonstrates Industry-Leading Innovations with Graphene-Enhanced Building Materials
IMPERIAL VALLEY, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- Premier Graphene, Inc. (OTC: BIEI), a trailblazing company in the bio graphene sector, proudly announces groundbreaking achievements in the integration of graphene with construction materials, marking a significant leap forward in the construction and materials science industries. Through meticulous research and testing, Premier Graphene, Inc. has demonstrated the remarkable potential of graphene to revolutionize the building materials
GlobeNewswirePremier Biomedical Inc. (BIEI), now known as Premier Graphene, Inc., engages Gustavo Carreño as Chief Technology Officer (CTO)
Mr. Carreño’s experience and connections in Mexico furnishes Premier with unique advantages for closing its pending transactionsIMPERIAL VALLEY, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Premier Graphene Inc. (OTC: BIEI) proudly announces the appointment of visionary industry leader, Gustavo Carreño, as its new Chief Technology Officer (CTO). Mr. Carreño is poised to steer the Company into a future defined by groundbreaking innovation and transformative growth. With a proven track record at the
